GB0612542D0 - Combinations comprising staurosporines - Google Patents

Combinations comprising staurosporines

Info

Publication number
GB0612542D0
GB0612542D0 GBGB0612542.1A GB0612542A GB0612542D0 GB 0612542 D0 GB0612542 D0 GB 0612542D0 GB 0612542 A GB0612542 A GB 0612542A GB 0612542 D0 GB0612542 D0 GB 0612542D0
Authority
GB
United Kingdom
Prior art keywords
staurosporines
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0612542.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0612542.1A priority Critical patent/GB0612542D0/en
Publication of GB0612542D0 publication Critical patent/GB0612542D0/en
Priority to US12/305,390 priority patent/US20100184820A1/en
Priority to MX2008016488A priority patent/MX2008016488A/es
Priority to JP2009515774A priority patent/JP2009541240A/ja
Priority to KR1020097001396A priority patent/KR20090033874A/ko
Priority to RU2009101972/15A priority patent/RU2009101972A/ru
Priority to BRPI0713730-3A priority patent/BRPI0713730A2/pt
Priority to PCT/EP2007/005517 priority patent/WO2007147613A2/en
Priority to CNA200780030602XA priority patent/CN101505760A/zh
Priority to AU2007263278A priority patent/AU2007263278A1/en
Priority to CA002655724A priority patent/CA2655724A1/en
Priority to EP07764787A priority patent/EP2037933A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0612542.1A 2006-06-23 2006-06-23 Combinations comprising staurosporines Ceased GB0612542D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB0612542.1A GB0612542D0 (en) 2006-06-23 2006-06-23 Combinations comprising staurosporines
EP07764787A EP2037933A2 (en) 2006-06-23 2007-06-22 Combinations comprising staurosprorines
KR1020097001396A KR20090033874A (ko) 2006-06-23 2007-06-22 스타우로스포린을 포함하는 조합물
MX2008016488A MX2008016488A (es) 2006-06-23 2007-06-22 Combinaciones que comprenden estaurosporinas.
JP2009515774A JP2009541240A (ja) 2006-06-23 2007-06-22 スタウロスポリンを含む組み合わせ
US12/305,390 US20100184820A1 (en) 2006-06-23 2007-06-22 Combinations comprising staurosporines
RU2009101972/15A RU2009101972A (ru) 2006-06-23 2007-06-22 Комбинации, содержащие стауроспорины
BRPI0713730-3A BRPI0713730A2 (pt) 2006-06-23 2007-06-22 combinações compreendendo estaurosporinas
PCT/EP2007/005517 WO2007147613A2 (en) 2006-06-23 2007-06-22 Combinations comprising staurosprorines
CNA200780030602XA CN101505760A (zh) 2006-06-23 2007-06-22 包含星形孢菌素类的组合
AU2007263278A AU2007263278A1 (en) 2006-06-23 2007-06-22 Combinations comprising staurosprorines
CA002655724A CA2655724A1 (en) 2006-06-23 2007-06-22 Combinations comprising staurosprorines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0612542.1A GB0612542D0 (en) 2006-06-23 2006-06-23 Combinations comprising staurosporines

Publications (1)

Publication Number Publication Date
GB0612542D0 true GB0612542D0 (en) 2006-08-02

Family

ID=36803826

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0612542.1A Ceased GB0612542D0 (en) 2006-06-23 2006-06-23 Combinations comprising staurosporines

Country Status (12)

Country Link
US (1) US20100184820A1 (cg-RX-API-DMAC7.html)
EP (1) EP2037933A2 (cg-RX-API-DMAC7.html)
JP (1) JP2009541240A (cg-RX-API-DMAC7.html)
KR (1) KR20090033874A (cg-RX-API-DMAC7.html)
CN (1) CN101505760A (cg-RX-API-DMAC7.html)
AU (1) AU2007263278A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0713730A2 (cg-RX-API-DMAC7.html)
CA (1) CA2655724A1 (cg-RX-API-DMAC7.html)
GB (1) GB0612542D0 (cg-RX-API-DMAC7.html)
MX (1) MX2008016488A (cg-RX-API-DMAC7.html)
RU (1) RU2009101972A (cg-RX-API-DMAC7.html)
WO (1) WO2007147613A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009143578A1 (en) * 2008-05-28 2009-12-03 The Council Of The Queensland Institute Of Medical Research Cancer drug target and methods of diagnosis and therapy
CN102101866A (zh) * 2010-11-04 2011-06-22 中国海洋大学 十字孢碱卤代衍生物及其制备方法和应用
FI20115640A0 (fi) * 2011-06-22 2011-06-22 Turun Yliopisto Yhdistelmähoito
FI20115876A0 (fi) 2011-09-06 2011-09-06 Turun Yliopisto Yhdistelmähoito
CA2878873C (en) 2012-07-13 2018-08-21 Turun Yliopisto A pharmaceutical combination including a histone deacetylase 4 (hdac4) silencing agent for treating cancer
CN110526903B (zh) * 2016-06-01 2021-12-10 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途
CN106083830B (zh) * 2016-06-01 2019-07-12 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途
SG10201607303YA (en) * 2016-09-01 2018-04-27 Agency Science Tech & Res Antisense oligonucleotides to induce exon skipping
WO2019000224A1 (zh) * 2017-06-27 2019-01-03 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途
CN107569491A (zh) * 2017-08-30 2018-01-12 杭州科兴生物化工有限公司 一种星孢菌素类化合物的应用
TWI861509B (zh) 2021-06-11 2024-11-11 美商基利科學股份有限公司 Mcl-1抑制劑與抗體藥物接合物之組合
JP7900421B2 (ja) 2021-06-11 2026-08-04 ギリアード サイエンシーズ, インコーポレイテッド Mcl-1阻害剤と抗がん剤との組み合わせ
CN114437109B (zh) * 2022-03-08 2023-09-29 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种十字孢碱卤代衍生物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001992A (en) * 1999-01-07 1999-12-14 Isis Pharmaceuticals Inc. Antisense modulation of novel anti-apoptotic bcl-2-related proteins
PT1441737E (pt) * 2001-10-30 2006-12-29 Dana Farber Cancer Inst Inc Derivados de estrutura como inibidores da actividade do receptor de tirosina cinase flt3
EP1653973A1 (en) * 2003-08-08 2006-05-10 Novartis AG Combinations comprising staurosporines

Also Published As

Publication number Publication date
WO2007147613A3 (en) 2008-07-03
RU2009101972A (ru) 2010-07-27
US20100184820A1 (en) 2010-07-22
CN101505760A (zh) 2009-08-12
CA2655724A1 (en) 2007-12-27
BRPI0713730A2 (pt) 2012-10-30
WO2007147613A2 (en) 2007-12-27
KR20090033874A (ko) 2009-04-06
AU2007263278A1 (en) 2007-12-27
EP2037933A2 (en) 2009-03-25
MX2008016488A (es) 2009-01-22
JP2009541240A (ja) 2009-11-26

Similar Documents

Publication Publication Date Title
DE602007002700D1 (en) Interventionsfreies frac-system
EP2078282A4 (en) E-couponing
DE602007008085D1 (en) Dihydropyrazolopyrimidinonderivate
DE602007014031D1 (en) Luftreifensatz
DE602007002070D1 (en) 2-pyrazincarboxamidderivate
DE602007001601D1 (en) Glasuntersuchung
EP1983992A4 (en) 2-IMINO-BENZIMIDAZOLES
DE602007003855D1 (en) Isothermer reaktor
ZA200902278B (en) Aminomethyl-4-imidazoles
DE602007006989D1 (en) Spiropiperidinderivate
EP2084019A4 (en) PAINT SCRAPER
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
DE602007011622D1 (en) Penem-prodrugs
EP2024567A4 (en) TONTAPETE
EP2007388A4 (en) OPIOPATHIEN
DK1989111T3 (en) Satellitluftbremseapparat
EP1974618A4 (en) UNDERWEAR
DE502007001126D1 (en) Eiten
GB0601584D0 (en) Cosyhold headscarf
GB0602258D0 (en) Privyphone
AU3514P (en) ARCBENT Arctotis fastuosa
AU4914P (en) CalflatGL Calothamnus quadrifidus
GB0601463D0 (en) Playmat
AP00261S1 (en) Woodstove
GB0600152D0 (en) Cup-1

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)